GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB.WS) » Definitions » LT-Debt-to-Total-Asset

Nuvation Bio (Nuvation Bio) LT-Debt-to-Total-Asset : 0.00 (As of Sep. 2021)


View and export this data going back to 2020. Start your Free Trial

What is Nuvation Bio LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Nuvation Bio's long-term debt to total assests ratio for the quarter that ended in Sep. 2021 was 0.00.

Nuvation Bio's long-term debt to total assets ratio stayed the same from Sep. 2020 (0.00) to Sep. 2021 (0.00).

Nuvation Bio LT-Debt-to-Total-Asset Historical Data

The historical data trend for Nuvation Bio's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio LT-Debt-to-Total-Asset Chart

Nuvation Bio Annual Data
Trend Dec20 Dec21
LT-Debt-to-Total-Asset
- -

Nuvation Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
LT-Debt-to-Total-Asset Get a 7-Day Free Trial - - - - -

Nuvation Bio LT-Debt-to-Total-Asset Calculation

Nuvation Bio's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2020 is calculated as

LT Debt to Total Assets (A: Dec. 2020 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2020 )/Total Assets (A: Dec. 2020 )
=0/145.004
=

Nuvation Bio's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2021 is calculated as

LT Debt to Total Assets (Q: Sep. 2021 )=Long-Term Debt & Capital Lease Obligation (Q: Sep. 2021 )/Total Assets (Q: Sep. 2021 )
=0/797.791
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nuvation Bio  (NYSE:NUVB.WS) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Nuvation Bio LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuvation Bio (Nuvation Bio) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB.WS) » Definitions » LT-Debt-to-Total-Asset
Comparable Companies
Traded in Other Exchanges
N/A
Address
1500 Broadway, Suite 1401, New York, NY, USA, 10036
Website
https://www.nuvationbio.com
Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.